|Podcasts|January 11, 2022
Data Aggregation and AI in Use Today
Author(s)Lisa Henderson, Andy Studna, Senior Editor
Martin Gouldstone, Chief Business Officer of Life Sciences, Sensyne, updates us on the status of AI in data used for clinical research, the difference between ethical AI vs. AI, and what Sensyne is trying to achieve in this space.
Martin Gouldstone, Chief Business Officer of Life Sciences, Sensyne, updates us on the status of AI in data used for clinical research, the difference between ethical AI vs. AI, and what Sensyne is trying to achieve in this space.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Content
Trending on Applied Clinical Trials Online
1
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
2
SCOPE Summit 2026: Where AI Is Making the Most Immediate Impact Across R&D
3
Meeting Halfway: Co-Developing Frameworks for Seamless FSO to FSP Transitions
4
De-Risking Development: Prioritizing Robustness in Trial Design
5